Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | NSD2 | O96028 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28451989 | 0.87 | CA12 (0.50) | SIRT1ALDH1A1HPGDCA12CA1 | |
| SCHEMBL20591207 | 0.87 | SIRT1 (0.51) | SIRT1ALDH1A1HPGDL3MBTL1CA12 | |
| SCHEMBL27780108 | 0.85 | SIRT1 (0.54) | SIRT1ALDH1A1HPGDL3MBTL1CA12 | |
| SCHEMBL2306567 | 0.85 | CHRM2 (0.54) | SIRT1ALDH1A1HPGDL3MBTL1NSD2 | |
| SCHEMBL12504708 | 0.85 | SIRT1 (0.50) | SIRT1ALDH1A1HPGDL3MBTL1CA12 | |
| SCHEMBL26842232 | 0.85 | SIRT1 (0.50) | SIRT1ALDH1A1HPGDL3MBTL1NSD2 | |
| SCHEMBL599930 | 0.85 | SIRT1 (0.50) | SIRT1ALDH1A1HPGDL3MBTL1CA12 | |
| SCHEMBL8959187 | 0.83 | SIRT1 (0.71) | SIRT1ALDH1A1HPGDL3MBTL1CA12 | |
| SCHEMBL231042 | 0.83 | SIRT1 (0.71) | SIRT1ALDH1A1HPGDL3MBTL1CA12 | |
| Acetophenone SCHEMBL28395442 | 0.83 | ALDH1A1 (0.59) | SIRT1ALDH1A1HPGDL3MBTL1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101687781-B | Compound for photoacid generator and use its anti-corrosion agent composition, pattern formation method | CENTRAL GLASS CO.,LTD. (JP) | 2015-08-12 | — | — | CN | disclosed |
| EP-2533610-A1 | Composition for Charge-Transport Film and Ionic Compound, Charge-Transport Film and Organic Electroluminescence Device Using the Same, and Production Method of the Organic Electruminescence Device and Production Method of the Charge-Transport Film | Mitsubishi Chemical Corporation (JP) | 2012-12-12 | — | — | EP | disclosed |
| EP-2235029-B1 | NICKEL COMPLEXING COMPOUNDS CONTAINING DIARYL SULFIDE LIGANDS | BASF SE (DE) | 2011-09-21 | — | — | EP | disclosed |
| EP-2235029-A1 | NICKEL COMPLEXING COMPOUNDS CONTAINING DIARYL SULFIDE LIGANDS | BASF SE (DE) | 2010-10-06 | — | — | EP | disclosed |
| CN-101687781-A | Compound for photoacid generator, resist composition using the same, and pattern-forming method | CENTRAL GLASS CO LTD | 2010-03-31 | — | — | CN | disclosed |
| WO-2009083435-A1 | NICKEL COMPLEXING COMPOUNDS CONTAINING DIARYL SULFIDE LIGANDS | BASF SE (DE) | 2009-07-09 | — | — | WO | disclosed |
| US-7482344-B2 | Tricyclic steroid hormone nuclear receptor modulators | ELI LILLY AND COMPANY (US) | 2009-01-27 | — | — | US | disclosed |
| US-20070088016-A1 | Tricyclic steroid hormone nuclear receptor modulators | ELI LILLY AND COMPANY | 2007-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070088016-A1 | Tricyclic steroid hormone nuclear receptor modulators | NR3C2, NR3C1, NR5A1 | SIRT1 497/4885ALDH1A1 2206/4885HPGD 318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.